Tumor Vasculature

Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
Stefanie Linch, Melissa J Kasiewicz, Michael McNamara, Ian Hilgart, Mohammad Farhad, William Redmond

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P306; DOI: 10.1186/2051-1426-3-S2-P306
Tumor vascular normalization as a strategy to potentiate effectiveness of therapeutic vaccines
Benedetto Farsaci, Renee N Donahue, Michael A Coplin, Italia Grenga, Lauren Lepone, Alfredo A Molinolo, James W Hodge

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P204; DOI: 10.1186/2051-1426-2-S3-P204
Targeting the tumor vasculature with TEM8-specific T cells
LaTerrica C Williams, Sunitha Kakarla, Simone Krebs, Thuy Phung, David Rowley, Stephen Gottschalk

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P42; DOI: 10.1186/2051-1426-2-S3-P42
Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248
Chunsheng Li, Junying Wang, Jia Hu, Ann Marie Chacko, Aizhi Zhao, Chaitanya Divgi, Vladimir Muzykantov, George Coukos

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P81; DOI: 10.1186/2051-1426-1-S1-P81
Vascular normalization: a strategy to recondition the tumor immune microenvironment
Yuhui Huang, Jianping Yuan, Elda Righi, Dan G Duda, Dai Fukumura, Mark C Poznansky, Rakesh K Jain

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P155; DOI: 10.1186/2051-1426-1-S1-P155

Log in using your username and password

Main menu

Log in using your username and password

You are here

Tumor Vasculature